NCT02521168 - Oral Triiodothyronine for Children Undergoing Cardiopulmonary Bypass in Indonesia | Biotech Hunter

Enrollment

177

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

January 31, 2015

Conditions

Postoperative; Dysfunction Following Cardiac Surgery

Interventions

DRUG

Oral triiodothyronine

Oral triiodothyronine is given peri-operatively through naso-gastric tube

DRUG

Placebo

Placebo consist of saccharin lactis that has the same appearance as Tetronine

Trial Locations (1)

Pediatric Cardiac ICU National Cardiovascular Center Harapan Kita, Jakarta